Your shopping cart is currently empty

Ac-YVAD-CHO (L 709049) is a selective and potent tetrapeptide interleukin 1β-converting enzyme (ICE) and caspase-1 (ICE)-like protease inhibitor with anti-inflammatory activity, inhibits cancer cell growth, and inhibits the production of mature IL-lβ. Ac-YVAD-CHO attenuates quinolinic acid-induced p53 increase and apoptosis in rat striatum.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $73 | In Stock | In Stock | |
| 5 mg | $289 | In Stock | In Stock | |
| 10 mg | $428 | - | In Stock | |
| 25 mg | $698 | - | In Stock | |
| 50 mg | $968 | - | In Stock |
| Description | Ac-YVAD-CHO (L 709049) is a selective and potent tetrapeptide interleukin 1β-converting enzyme (ICE) and caspase-1 (ICE)-like protease inhibitor with anti-inflammatory activity, inhibits cancer cell growth, and inhibits the production of mature IL-lβ. Ac-YVAD-CHO attenuates quinolinic acid-induced p53 increase and apoptosis in rat striatum. |
| Targets&IC50 | IL-1β (human):0.7 μM, IL-1β (mouse):2.5 μM |
| In vitro | Ac-YVAD-CHO reduced the elevation of IL-1β in LPS-treated plasma and peritoneal fluid.Ac-YVAD-CHO inhibited IL-1β with IC50=2.5 μM (mouse) and IC50=0.7 μM (human) in both mouse and human. [1] 15.6 μM Ac-YVAD-CHO inhibited NO-induced PARP cleavage and reduced NO-induced apoptosis in SNAP-treated thymocytes. [2] |
| In vivo | 30 mg/kg intraperitoneal injection of Ac-YVAD-CHO inhibited IL-1β levels in the blood of P. acnes sensitized mice. [1] Intrastriatal infusion of 2-8 μg Ac-YVAD-CHO attenuated quinolinic acid (QA)-induced apoptosis in rat striatum. [3] |
| Synonyms | L-709049, L709049, L 709049 |
| Molecular Weight | 492.52 |
| Formula | C23H32N4O8 |
| Cas No. | 143313-51-3 |
| Smiles | [C@@H](NC([C@H](CC1=CC=C(O)C=C1)NC(C)=O)=O)(C(N[C@H](C(N[C@@H](CC(O)=O)C=O)=O)C)=O)C(C)C |
| Relative Density. | 1.276 g/cm3 (Predicted) |
| Sequence | Ac-Tyr-Val-Ala-Asp-al |
| Sequence Short | YVAD-CHO |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 50 mg/mL (101.52 mM), Sonication is recommended. DMSO: 2 mg/mL (4.06 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.